Deubiquitination and Stabilization of PD-L1 by CSN5

Seung Oe Lim, Chia Wei Li, Weiya Xia, Jong Ho Cha, Li Chuan Chan, Yun Wu, Shih Shin Chang, Wan Chi Lin, Jung Mao Hsu, Yi Hsin Hsu, Taewan Kim, Wei Chao Chang, Jennifer L. Hsu, Hirohito Yamaguchi, Qingqing Ding, Yan Wang, Yi Yang, Chung Hsuan Chen, Aysegul A. Sahin, Dihua YuGabriel N. Hortobagyi, Mien Chie Hung

Research output: Contribution to journalArticlepeer-review

521 Scopus citations

Abstract

Pro-inflammatory cytokines produced in the tumor microenvironment lead to eradication of anti-tumor immunity and enhanced tumor cell survival. In the current study, we identified tumor necrosis factor alpha (TNF-α) as a major factor triggering cancer cell immunosuppression against T cell surveillance via stabilization of programmed cell death-ligand 1 (PD-L1). We demonstrated that COP9 signalosome 5 (CSN5), induced by NF-κB p65, is required for TNF-α-mediated PD-L1 stabilization in cancer cells. CSN5 inhibits the ubiquitination and degradation of PD-L1. Inhibition of CSN5 by curcumin diminished cancer cell PD-L1 expression and sensitized cancer cells to anti-CTLA4 therapy.

Original languageEnglish (US)
Pages (from-to)925-939
Number of pages15
JournalCancer cell
Volume30
Issue number6
DOIs
StatePublished - Dec 12 2016

Keywords

  • CSN5
  • PD-L1
  • TNF-α
  • anti-CTLA4
  • curcumin
  • deubiquitination

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

MD Anderson CCSG core facilities

  • Advanced Technology Genomics Core
  • Flow Cytometry and Cellular Imaging Facility
  • Functional Genomics Core
  • Research Animal Support Facility
  • Tissue Biospecimen and Pathology Resource
  • Cytogenetics and Cell Authentication Core

Fingerprint

Dive into the research topics of 'Deubiquitination and Stabilization of PD-L1 by CSN5'. Together they form a unique fingerprint.

Cite this